US Stock MarketDetailed Quotes

Atea Pharmaceuticals (AVIR)

Watchlist
  • 4.570
  • -0.930-16.91%
Close May 13 16:00 ET
  • 4.570
  • 0.0000.00%
Post 20:01 ET
365.72MMarket Cap-2.17P/E (TTM)

Atea Pharmaceuticals (AVIR) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-51.79%-46.39M
2.56%-132.03M
7.15%-28.22M
-75.28%-40.38M
22.11%-32.87M
23.33%-30.56M
-58.67%-135.5M
-39.22%-30.4M
-30.95%-23.04M
-161.80%-42.2M
Net income from continuing operations
-32.59%-45.44M
5.96%-158.35M
-33.76%-44.87M
-34.98%-42.05M
8.29%-37.16M
45.75%-34.27M
-23.85%-168.39M
14.35%-33.54M
6.01%-31.15M
-43.78%-40.52M
Depreciation and amortization
0.00%104K
0.00%416K
0.00%104K
0.00%104K
0.00%104K
0.00%104K
0.00%416K
0.00%104K
0.00%104K
0.00%104K
Deferred tax
----
---6.36M
----
----
----
----
--0
----
----
----
Change In working capital
-161.71%-4.2M
320.47%16.48M
323.82%19.12M
-20.31%-1.87M
107.33%841K
-111.39%-1.61M
-146.25%-7.48M
-190.74%-8.54M
-121.08%-1.56M
-447.56%-11.48M
-Change in prepaid assets
408.78%1.97M
-125.82%-1.53M
0.43%-2.33M
-1,612.90%-938K
-23.64%2.38M
-112.57%-638K
217.27%5.91M
43.69%-2.34M
-98.64%62K
461.72%3.12M
-Change in payables and accrued expense
-289.50%-6.21M
259.95%21.14M
397.41%19.16M
115.14%195K
89.75%-1.49M
-63.88%3.28M
-192.01%-13.22M
-147.32%-6.44M
-145.24%-1.29M
-472.35%-14.56M
-Change in other current assets
102.10%88K
---2.94M
714.98%2.34M
-276.66%-1.08M
--0
---4.2M
--0
--287K
---287K
--0
-Change in other current liabilities
-12.77%-53K
-8.57%-190K
-4.44%-47K
-11.63%-48K
-11.63%-48K
-6.82%-47K
-8.70%-175K
-9.76%-45K
-7.50%-43K
-10.26%-43K
Cash from discontinued investing activities
Operating cash flow
-51.79%-46.39M
2.56%-132.03M
7.15%-28.22M
-75.28%-40.38M
22.11%-32.87M
23.33%-30.56M
-58.67%-135.5M
-39.22%-30.4M
-30.95%-23.04M
-161.80%-42.2M
Investing cash flow
Cash flow from continuing investing activities
-65.26%29.74M
236.50%188.79M
1,482.55%46.59M
133.85%41.3M
-87.74%15.29M
50.71%85.61M
39.21%56.11M
-112.13%-3.37M
-108.52%-122.01M
167.77%124.69M
Net investment purchase and sale
-65.26%29.74M
236.50%188.79M
1,482.55%46.59M
133.85%41.3M
-87.74%15.29M
50.71%85.61M
39.21%56.11M
-112.13%-3.37M
-108.52%-122.01M
167.77%124.69M
Cash from discontinued investing activities
Investing cash flow
-65.26%29.74M
236.50%188.79M
1,482.55%46.59M
133.85%41.3M
-87.74%15.29M
50.71%85.61M
39.21%56.11M
-112.13%-3.37M
-108.52%-122.01M
167.77%124.69M
Financing cash flow
Cash flow from continuing financing activities
174.06%257K
-9,742.32%-25.75M
0
-9,762.39%-11.31M
-14.09M
-331.33%-347K
3.89%267K
0
27.17%117K
0
Net common stock issuance
-53.81%-746K
---25.46M
--58K
---11.43M
---13.61M
---485K
--0
--0
--0
----
Proceeds from stock option exercised by employees
626.81%1M
-24.72%201K
--427K
3.42%121K
---485K
-8.00%138K
3.89%267K
--0
27.17%117K
--0
Net other financing activities
----
---485K
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
174.06%257K
-9,742.32%-25.75M
--0
-9,762.39%-11.31M
---14.09M
-331.33%-347K
3.89%267K
--0
27.17%117K
--0
Net cash flow
Beginning cash position
47.94%95.71M
-55.02%64.7M
-21.45%77.34M
-63.96%87.72M
-25.80%119.39M
-55.02%64.7M
-23.77%143.82M
-28.59%98.46M
13.79%243.39M
-12.29%160.91M
Current changes in cash
-129.98%-16.4M
139.20%31.02M
154.40%18.37M
92.84%-10.38M
-138.40%-31.67M
220.11%54.7M
-76.48%-79.13M
-668.76%-33.77M
-90.67%-144.93M
170.93%82.48M
End cash Position
-33.57%79.32M
47.94%95.71M
47.94%95.71M
-21.45%77.34M
-63.96%87.72M
-25.80%119.39M
-55.02%64.7M
-55.02%64.7M
-28.59%98.46M
13.79%243.39M
Free cash flow
-51.79%-46.39M
2.56%-132.03M
7.15%-28.22M
-75.28%-40.38M
22.11%-32.87M
23.33%-30.56M
-58.67%-135.5M
-39.22%-30.4M
-30.95%-23.04M
-161.80%-42.2M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -51.79%-46.39M2.56%-132.03M7.15%-28.22M-75.28%-40.38M22.11%-32.87M23.33%-30.56M-58.67%-135.5M-39.22%-30.4M-30.95%-23.04M-161.80%-42.2M
Net income from continuing operations -32.59%-45.44M5.96%-158.35M-33.76%-44.87M-34.98%-42.05M8.29%-37.16M45.75%-34.27M-23.85%-168.39M14.35%-33.54M6.01%-31.15M-43.78%-40.52M
Depreciation and amortization 0.00%104K0.00%416K0.00%104K0.00%104K0.00%104K0.00%104K0.00%416K0.00%104K0.00%104K0.00%104K
Deferred tax -------6.36M------------------0------------
Change In working capital -161.71%-4.2M320.47%16.48M323.82%19.12M-20.31%-1.87M107.33%841K-111.39%-1.61M-146.25%-7.48M-190.74%-8.54M-121.08%-1.56M-447.56%-11.48M
-Change in prepaid assets 408.78%1.97M-125.82%-1.53M0.43%-2.33M-1,612.90%-938K-23.64%2.38M-112.57%-638K217.27%5.91M43.69%-2.34M-98.64%62K461.72%3.12M
-Change in payables and accrued expense -289.50%-6.21M259.95%21.14M397.41%19.16M115.14%195K89.75%-1.49M-63.88%3.28M-192.01%-13.22M-147.32%-6.44M-145.24%-1.29M-472.35%-14.56M
-Change in other current assets 102.10%88K---2.94M714.98%2.34M-276.66%-1.08M--0---4.2M--0--287K---287K--0
-Change in other current liabilities -12.77%-53K-8.57%-190K-4.44%-47K-11.63%-48K-11.63%-48K-6.82%-47K-8.70%-175K-9.76%-45K-7.50%-43K-10.26%-43K
Cash from discontinued investing activities
Operating cash flow -51.79%-46.39M2.56%-132.03M7.15%-28.22M-75.28%-40.38M22.11%-32.87M23.33%-30.56M-58.67%-135.5M-39.22%-30.4M-30.95%-23.04M-161.80%-42.2M
Investing cash flow
Cash flow from continuing investing activities -65.26%29.74M236.50%188.79M1,482.55%46.59M133.85%41.3M-87.74%15.29M50.71%85.61M39.21%56.11M-112.13%-3.37M-108.52%-122.01M167.77%124.69M
Net investment purchase and sale -65.26%29.74M236.50%188.79M1,482.55%46.59M133.85%41.3M-87.74%15.29M50.71%85.61M39.21%56.11M-112.13%-3.37M-108.52%-122.01M167.77%124.69M
Cash from discontinued investing activities
Investing cash flow -65.26%29.74M236.50%188.79M1,482.55%46.59M133.85%41.3M-87.74%15.29M50.71%85.61M39.21%56.11M-112.13%-3.37M-108.52%-122.01M167.77%124.69M
Financing cash flow
Cash flow from continuing financing activities 174.06%257K-9,742.32%-25.75M0-9,762.39%-11.31M-14.09M-331.33%-347K3.89%267K027.17%117K0
Net common stock issuance -53.81%-746K---25.46M--58K---11.43M---13.61M---485K--0--0--0----
Proceeds from stock option exercised by employees 626.81%1M-24.72%201K--427K3.42%121K---485K-8.00%138K3.89%267K--027.17%117K--0
Net other financing activities -------485K--------------------------------
Cash from discontinued financing activities
Financing cash flow 174.06%257K-9,742.32%-25.75M--0-9,762.39%-11.31M---14.09M-331.33%-347K3.89%267K--027.17%117K--0
Net cash flow
Beginning cash position 47.94%95.71M-55.02%64.7M-21.45%77.34M-63.96%87.72M-25.80%119.39M-55.02%64.7M-23.77%143.82M-28.59%98.46M13.79%243.39M-12.29%160.91M
Current changes in cash -129.98%-16.4M139.20%31.02M154.40%18.37M92.84%-10.38M-138.40%-31.67M220.11%54.7M-76.48%-79.13M-668.76%-33.77M-90.67%-144.93M170.93%82.48M
End cash Position -33.57%79.32M47.94%95.71M47.94%95.71M-21.45%77.34M-63.96%87.72M-25.80%119.39M-55.02%64.7M-55.02%64.7M-28.59%98.46M13.79%243.39M
Free cash flow -51.79%-46.39M2.56%-132.03M7.15%-28.22M-75.28%-40.38M22.11%-32.87M23.33%-30.56M-58.67%-135.5M-39.22%-30.4M-30.95%-23.04M-161.80%-42.2M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More